Olympus (OLYMY) Stock Price, News & Analysis

Company Overview

Olympus Corporation is a Tokyo-based manufacturer specializing in precision technology for the medical, scientific and industrial markets. Established in 1919, the company has built an international reputation for optical and digital imaging solutions that encompass endoscopic systems, microscopes, cameras and related accessories. Olympus leverages its expertise in optics, mechanics and electronics to develop instruments designed to advance diagnostics and scientific discovery.

In the healthcare sector, Olympus is best known for its endoscopy products and therapeutic solutions that support minimally invasive procedures in gastroenterology, pulmonology and urology. The company’s medical portfolio also includes ultrasound systems, surgical visualization products and a range of single-use and reprocessable endoscopic accessories. Through ongoing research and development, Olympus aims to enhance procedural outcomes and improve patient comfort.

Beyond medicine, Olympus serves academic and industrial research communities with microscopes, imaging software and analytical instruments marketed under its Life Science division. The company’s Scientific Solutions unit supplies high-resolution microscopes and imaging systems for cell biology, materials analysis and quality-control applications. Its Industrial Solutions segment offers borescopes, scanners and non-destructive testing devices for aerospace, automotive and manufacturing clients.

Olympus operates across more than 40 countries, with major regional headquarters in Europe, North America and Asia-Pacific. Headquartered in Shinjuku, Tokyo, the company is led by President and Chief Executive Officer Yasuo Takeuchi, who has overseen strategic initiatives to expand digital imaging capabilities and strengthen Olympus’s global service network. Through targeted investments in innovation, Olympus continues to pursue growth in core markets and adjacent technology areas.

Key Stats

• Today's Range: $12.16 to $12.95
• 50-Day Range: $11.55 to $13.40
• 52-Week Range: $11.09 to $18.84
• Volume: 41,195 shs
• Average Volume: 123,711 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

OLYMY Stock Analysis - Frequently Asked Questions

How have OLYMY shares performed this year?

Olympus' stock was trading at $14.88 at the start of the year. Since then, OLYMY stock has decreased by 15.4% and is now trading at $12.5950.

How do I buy shares of Olympus?

Shares of OLYMY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:OLYMY
• CIK: N/A
• Web: www.olympus-global.com
• Phone: (133) 340-2111
• Fax: N/A
• Employees: 28,838
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A